Metraipolis › archive › dc_d5bfee78fdb1
Ellagic Acid and Metformin: In Vitro Synergy and Enhanced Cisplatin Efficacy In Vivo in Resistant Breast Cancer — Europe PMC PMID:42797030
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42797030
- DOI
- 10.3390/nu18183047
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-09T06:26:32.344Z
- SHA-256 of the archived text
7e7783391aa8ab84979cfe0805ef06664205085f3219576c172b898229c3e029- Stable URL of this page
https://metraipolis.com/documento/dc_d5bfee78fdb1
How to cite
Ellagic Acid and Metformin: In Vitro Synergy and Enhanced Cisplatin Efficacy In Vivo in Resistant Breast Cancer — Europe PMC PMID:42797030 — Europe PMC (en), https://europepmc.org/article/MED/42797030 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d5bfee78fdb1 (Metraipolis archive dc_d5bfee78fdb1, sha256 7e7783391aa8ab84979cfe0805ef06664205085f3219576c172b898229c3e029)
BibTeX
@misc{dcd5bfee78fdb1,
title = {Ellagic Acid and Metformin: In Vitro Synergy and Enhanced Cisplatin Efficacy In Vivo in Resistant Breast Cancer — Europe PMC PMID:42797030},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42797030},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d5bfee78fdb1; sha256 7e7783391aa8ab84979cfe0805ef06664205085f3219576c172b898229c3e029},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42797030. Agents can read the archived copy with the MCP tool read_document.